{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T14:12:25Z","timestamp":1790345545381,"version":"4.1.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T00:00:00Z","timestamp":1774828800000},"content-version":"vor","delay-in-days":88,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004581","name":"Brandenburg State Ministry of Science Research and Culture","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004581","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"publisher","award":["Ka2663\/3\\u20131"],"award-info":[{"award-number":["Ka2663\/3\\u20131"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Treatment and Research Communications"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.ctarc.2026.101194","type":"journal-article","created":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T06:57:46Z","timestamp":1774940266000},"page":"101194","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["PARK7 (DJ-1) indicates favorable prognosis and correlates with estrogen-receptor status and N\u03b5-carboxymethyl-lysine (CML) accumulation in breast cancer"],"prefix":"10.1016","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2563-0386","authenticated-orcid":false,"given":"Norbert","family":"Nass","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Sprung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atanas","family":"Ignatov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Kalinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ctarc.2026.101194_bib0001","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20211033","article-title":"Understanding breast cancer as a global health concern","volume":"95","author":"Wilkinson","year":"2022","journal-title":"Br. J. Radiol."},{"key":"10.1016\/j.ctarc.2026.101194_bib0002","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/s41568-020-0266-x","article-title":"Key steps for effective breast cancer prevention","volume":"20","author":"Britt","year":"2020","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ctarc.2026.101194_bib0003","article-title":"Global burden and projections of breast cancer incidence and mortality to 2050: a comprehensive analysis of GLOBOCAN data","volume":"13","author":"Freihat","year":"2025","journal-title":"Front. Pub. Health"},{"key":"10.1016\/j.ctarc.2026.101194_bib0004","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.6026\/9732063002002069","article-title":"Breast cancer histopathology, classification and Clinical management: current perspectives","volume":"20","author":"Waykar","year":"2024","journal-title":"Bioinformation"},{"key":"10.1016\/j.ctarc.2026.101194_bib0005","doi-asserted-by":"crossref","first-page":"10023","DOI":"10.1007\/s11033-022-07571-2","article-title":"Breast cancer in the era of precision medicine","volume":"49","author":"Sarhangi","year":"2022","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.ctarc.2026.101194_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.101920","article-title":"Protein glycation - biomarkers of metabolic dysfunction and early-stage decline in health in the era of precision medicine","volume":"42","author":"Rabbani","year":"2021","journal-title":"Redox Biol."},{"key":"10.1016\/j.ctarc.2026.101194_bib0007","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1515\/BC.2008.034","article-title":"Potential biomarkers of ageing","volume":"389","author":"Simm","year":"2008","journal-title":"Biol. Chem."},{"key":"10.1016\/j.ctarc.2026.101194_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodchem.2023.135735","article-title":"Dietary advanced glycation end products (dAGEs): an insight between modern diet and health","volume":"415","author":"Tian","year":"2023","journal-title":"Food Chem."},{"key":"10.1016\/j.ctarc.2026.101194_bib0009","doi-asserted-by":"crossref","first-page":"2802","DOI":"10.3390\/nu13082802","article-title":"Dietary AGEs as exogenous boosters of inflammation","volume":"13","author":"Garay-Sevilla","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.ctarc.2026.101194_bib0010","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.3390\/nu17101638","article-title":"Association of dietary advanced glycation end products with overall and site-specific cancer risk and mortality: a systematic review and meta-analysis","volume":"17","author":"Pascual-Morena","year":"2025","journal-title":"Nutrients"},{"key":"10.1016\/j.ctarc.2026.101194_bib0011","doi-asserted-by":"crossref","first-page":"45662","DOI":"10.1074\/jbc.M105374200","article-title":"Proteasome inhibition in glyoxal-treated fibroblasts and resistance of glycated glucose-6-phosphate dehydrogenase to 20 S Proteasome degradation in vitro","volume":"276","author":"Bulteau","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ctarc.2026.101194_bib0012","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.biocel.2010.01.012","article-title":"Glycation of PDGF results in decreased biological activity","volume":"42","author":"Nass","year":"2010","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.ctarc.2026.101194_bib0013","first-page":"239","article-title":"Glycation of extracellular matrix proteins impairs migration of immune cells","volume":"22","author":"Haucke","year":"2014","journal-title":"Wound Repair Regen. Off. Publ. Wound Heal. Soc. Eur. Tissue Repair Soc."},{"key":"10.1016\/j.ctarc.2026.101194_bib0014","article-title":"RAGE and its ligands in breast cancer progression and metastasis","volume":"18","author":"Coser","year":"2024","journal-title":"Oncol. Rev."},{"key":"10.1016\/j.ctarc.2026.101194_bib0015","doi-asserted-by":"crossref","first-page":"812","DOI":"10.37349\/etat.2023.00170","article-title":"AGEs and RAGE: metabolic and molecular signatures of the glycation-inflammation axis in malignant or metastatic cancers","volume":"4","author":"Palanissami","year":"2023","journal-title":"Explor. Target. Anti-Tumor Ther."},{"key":"10.1016\/j.ctarc.2026.101194_bib0016","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.bbagen.2016.03.006","article-title":"Oxidative stress and glyoxalase I activity mediate dicarbonyl toxicity in MCF-7 mamma carcinoma cells and a tamoxifen resistant derivative","volume":"1860","author":"Nass","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ctarc.2026.101194_bib0017","doi-asserted-by":"crossref","first-page":"869","DOI":"10.14348\/molcells.2022.0109","article-title":"Glyoxalase 1 as a therapeutic target in cancer and cancer stem cells","volume":"45","author":"Kim","year":"2022","journal-title":"Mol. Cells"},{"key":"10.1016\/j.ctarc.2026.101194_bib0018","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2024.110896","article-title":"Aldo-Keto reductases 7A subfamily: a mini review","volume":"391","author":"Zhao","year":"2024","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.ctarc.2026.101194_bib0019","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2111338119","article-title":"Parkinson\u2019s disease protein PARK7 prevents metabolite and protein damage caused by a glycolytic metabolite","volume":"119","author":"Heremans","year":"2022","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ctarc.2026.101194_bib0020","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1074\/jbc.M114.597815","article-title":"Parkinsonism-associated protein DJ-1\/Park7 is a major protein deglycase that repairs methylglyoxal- and glyoxal-glycated cysteine, arginine, and lysine residues","volume":"290","author":"Richarme","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ctarc.2026.101194_bib0021","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s10549-013-2523-0","article-title":"DJ-1 protein expression as a predictor of pathological complete remission after neoadjuvant chemotherapy in breast cancer patients","volume":"139","author":"Kawate","year":"2013","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.ctarc.2026.101194_bib0022","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1186\/s13058-025-02153-z","article-title":"The role and prognostic value of mitochondria-related gene PARK7 in breast cancer","volume":"27","author":"Yu","year":"2025","journal-title":"Breast Cancer Res. BCR"},{"key":"10.1016\/j.ctarc.2026.101194_bib0023","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1365-2559.2012.04202.x","article-title":"Clinical significance of DJ-1 as a secretory molecule: retrospective study of DJ-1 expression at mRNA and protein levels in ductal carcinoma of the breast","volume":"61","author":"Tsuchiya","year":"2012","journal-title":"Histopathology"},{"key":"10.1016\/j.ctarc.2026.101194_bib0024","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s10549-011-1584-1","article-title":"G-protein-coupled estrogen receptor GPR30 and tamoxifen resistance in breast cancer","volume":"128","author":"Ignatov","year":"2011","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.ctarc.2026.101194_bib0025","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s00418-016-1534-4","article-title":"Accumulation of the advanced glycation end product carboxymethyl lysine in breast cancer is positively associated with estrogen receptor expression and unfavorable prognosis in estrogen receptor-negative cases","volume":"147","author":"Nass","year":"2017","journal-title":"Histochem. Cell Biol."},{"key":"10.1016\/j.ctarc.2026.101194_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2020.153257","article-title":"Glyoxalase 1 expression analysis by immunohistochemistry in breast cancer","volume":"216","author":"Scheifele","year":"2020","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.ctarc.2026.101194_bib0027","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s00428-017-2154-7","article-title":"High neuronatin (NNAT) expression is associated with poor outcome in breast cancer","volume":"471","author":"Nass","year":"2017","journal-title":"Virchows Arch. Int. J. Pathol."},{"key":"10.1016\/j.ctarc.2026.101194_bib0028","doi-asserted-by":"crossref","first-page":"38408","DOI":"10.18632\/oncotarget.9493","article-title":"Expression of transmembrane protein 26 (TMEM26) in breast cancer and its association with drug response","volume":"7","author":"Nass","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.ctarc.2026.101194_bib0029","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0101473","article-title":"Differential response to \u03b1-oxoaldehydes in Tamoxifen resistant MCF-7 breast cancer cells","volume":"9","author":"Nass","year":"2014","journal-title":"PloS One."},{"key":"10.1016\/j.ctarc.2026.101194_bib0030","doi-asserted-by":"crossref","first-page":"916","DOI":"10.3390\/biom12070916","article-title":"Relationship of micro-RNA, mRNA and eIF expression in Tamoxifen-adapted MCF-7 breast cancer cells: impact of miR-1972 on gene expression, proliferation and migration","volume":"12","author":"Behringer","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.ctarc.2026.101194_bib0031","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1080\/15476286.2019.1581597","article-title":"Time resolved gene expression analysis during tamoxifen adaption of MCF-7 cells identifies long non-coding RNAs with prognostic impact","volume":"16","author":"Porsch","year":"2019","journal-title":"RNA Biol."},{"key":"10.1016\/j.ctarc.2026.101194_bib0032","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/nature10983","article-title":"The genomic and transcriptomic architecture of 2000 breast tumours reveals novel subgroups","volume":"486","author":"Curtis","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.ctarc.2026.101194_bib0033","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/nature11003","article-title":"The cancer cell line encyclopedia enables predictive modelling of anticancer drug sensitivity","volume":"483","author":"Barretina","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.ctarc.2026.101194_bib0034","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1007\/s00726-010-0783-0","article-title":"Methylglyoxal, glyoxalase 1 and the dicarbonyl proteome","volume":"42","author":"Rabbani","year":"2012","journal-title":"Amino Acid."},{"key":"10.1016\/j.ctarc.2026.101194_bib0035","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1042\/BJ20111648","article-title":"Transcriptional control of glyoxalase 1 by Nrf2 provides a stress-responsive defence against dicarbonyl glycation","volume":"443","author":"Xue","year":"2012","journal-title":"Biochem. J."},{"key":"10.1016\/j.ctarc.2026.101194_bib0036","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/jnc.15656","article-title":"DJ-1 is not a deglycase and makes a modest contribution to cellular defense against methylglyoxal damage in neurons","volume":"162","author":"Mazza","year":"2022","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ctarc.2026.101194_bib0037","first-page":"6944","article-title":"Role of DJ-1 siRNA in reverse sensitivity of breast cancer cells to chemotherapy and its possible mechanism","volume":"8","author":"Zhang","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.ctarc.2026.101194_bib0038","doi-asserted-by":"crossref","DOI":"10.1155\/2023\/5041223","article-title":"DJ-1: a potential biomarker related to prognosis, chemoresistance, and expression of microenvironmental chemokine in HR-positive breast cancer","volume":"2023","author":"Xie","year":"2023","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.ctarc.2026.101194_bib0039","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2017.06.010","article-title":"Defining a cancer dependency map","volume":"170","author":"Tsherniak","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.ctarc.2026.101194_bib0040","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.ccr.2005.02.010","article-title":"DJ-1, a novel regulator of the Tumor suppressor PTEN","volume":"7","author":"Kim","year":"2005","journal-title":"Cancer. Cell"},{"key":"10.1016\/j.ctarc.2026.101194_bib0041","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1165\/rcmb.2015-0304OC","article-title":"DJ-1 modulates nuclear erythroid 2-related factor-2-mediated protection in Human primary alveolar type II cells in smokers","volume":"55","author":"Bahmed","year":"2016","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.ctarc.2026.101194_bib0042","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/978-981-10-6583-5_7","article-title":"Transcriptional regulation of DJ-1","volume":"1037","author":"Takahashi-Niki","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.ctarc.2026.101194_bib0043","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/s42255-022-00710-w","article-title":"Lactylome analysis suggests lactylation-dependent mechanisms of metabolic adaptation in hepatocellular carcinoma","volume":"5","author":"Yang","year":"2023","journal-title":"Nat. Metab."},{"key":"10.1016\/j.ctarc.2026.101194_bib0044","doi-asserted-by":"crossref","first-page":"7409","DOI":"10.3390\/ijms24087409","article-title":"The tale of DJ-1 (PARK7): a Swiss Army knife in biomedical and psychological research","volume":"24","author":"Sun","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ctarc.2026.101194_bib0045","doi-asserted-by":"crossref","DOI":"10.1111\/jcmm.18041","article-title":"FKBP3 Aggravates the malignant phenotype of diffuse large B-cell lymphoma by PARK7-mediated activation of wnt\/\u03b2-catenin signalling","volume":"28","author":"Xing","year":"2024","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.ctarc.2026.101194_bib0046","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s00428-021-03238-8","article-title":"BCL3 Expression is strongly associated with the occurrence of breast cancer relapse under tamoxifen treatment in a retrospective cohort study","volume":"480","author":"Czapiewski","year":"2022","journal-title":"Virchows Arch. Int. J. Pathol."}],"container-title":["Cancer Treatment and Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S246829422600105X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S246829422600105X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T11:55:25Z","timestamp":1780919725000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S246829422600105X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":46,"alternative-id":["S246829422600105X"],"URL":"https:\/\/doi.org\/10.1016\/j.ctarc.2026.101194","relation":{},"ISSN":["2468-2942"],"issn-type":[{"value":"2468-2942","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PARK7 (DJ-1) indicates favorable prognosis and correlates with estrogen-receptor status and N\u03b5-carboxymethyl-lysine (CML) accumulation in breast cancer","name":"articletitle","label":"Article Title"},{"value":"Cancer Treatment and Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctarc.2026.101194","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101194"}}